A large number of chronic conditions, including cancer, are associated uniquely with decrements in health utility. The cumulative effects of comorbid conditions have substantial impact on daily functioning and well-being of Medicare beneficiaries.
The burden of cancer is not experienced equally across the population: Nationwide, black Americans have higher rates of death from cancer than white Americans, and nowhere has this disparity been more apparent than in the nation's capital, writes Rebecca Anhang Price.
Across the United States in 2009, overall cancer incidence was 4 percent higher among blacks than among whites. The disparity was more striking in Washington, D.C., where the overall cancer incidence among black residents was 54 percent higher than the incidence among white residents.
Across the United States in 2009, overall cancer incidence was 4 percent higher among blacks than among whites. The disparity was more striking in Washington, D.C., where the overall cancer incidence among black residents was 54 percent higher than the incidence among white residents.
Few patients 75 years of age and older participate in clinical trials, thus whether adjuvant chemotherapy for stage III colon cancer (CC) benefits this group is unknown.
This Statistical Brief presents data from the Healthcare Cost and Utilization Project (HCUP) on hospital stays for cancer care in individuals under 18 years of age in 2009.
The higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States.
Assessments of the medical and economic value of therapies in diseases such as cancer traditionally focus on average or median gains in patients' survival.
The addition of oxaliplatin to 5-FU appears to be associated with better survival among patients receiving adjuvant colon cancer treatment in the community.
Physician co-management, representing joint participation in the planning, decision-making, and delivery of care, is often cited in association with coordination of care. Yet little is known about how physicians manage tasks and how their management style impacts patient outcomes.
Experts agree on many key issues regarding anaplastic large cell lymphoma in women with breast implants, but substantial research is needed to improve our understanding of the epidemiology, clinical aspects, and biology of this disease.
US and Canadian differences in cancer screening due to each country's guidelines can potentially explain cross-country differences in breast cancer mortality and affect interpretation of international comparisons of cancer statistics.
Breast implants appear to be associated with a rare form of lymphoma, but there is not yet evidence to show that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop.
Decreased use of myeloid colony-stimulating factors in patients at lower or intermediate risk of febrile neutropenia from high-risk chemotherapy regimens could yield substantial cost savings without compromising patient outcomes.
